About us

Browse products

Innovative drug market in Central Europe to develop by 2-7% per annum between 2018 and 2023

June 2018

Among the five Central European countries: Bulgaria, Romania, Hungary, Slovakia and the Czech Republic, sales of innovative drugs will exhibit the most rapid rate of growth in Bulgaria, and the least rapid in the Czech Republic. Romania, Hungary and Slovakia will boast a stable annual sales value increase in this group of drugs – of around 5-6% per annum for 2018-2023, according to the latest PMR report “Generic and innovative drugs market in Central Europe 2018. Market analysis and development forecasts for 2018-2023”.

This press release was prepared based on the data from PMR's latest report entitled Generic and innovative drugs market in CE 2018. Market analysis and development forecasts for 2018-2023

Subscribe to receive full versions of PMR press releases:

Privacy Policy

view complete list of pharma & healthcare press releases »